Targeting the PD-1/PD-L1 Immune Checkpoint in EGFR-Mutated or ALK-Translocated Non-Small-Cell Lung Cancer - Université de Bretagne Occidentale
Article Dans Une Revue Targeted Oncology Année : 2017

Targeting the PD-1/PD-L1 Immune Checkpoint in EGFR-Mutated or ALK-Translocated Non-Small-Cell Lung Cancer

Fichier non déposé

Dates et versions

hal-02048079 , version 1 (25-02-2019)

Identifiants

  • HAL Id : hal-02048079 , version 1

Citer

Olivier Bylicki, Nicolas Paleiron, Jacques Margery, Florian Guisier, Alain Vergnenegre, et al.. Targeting the PD-1/PD-L1 Immune Checkpoint in EGFR-Mutated or ALK-Translocated Non-Small-Cell Lung Cancer. Targeted Oncology, 2017, 12 (5), pp.563-569. ⟨hal-02048079⟩
32 Consultations
0 Téléchargements

Partager

More